Видео ютуба по тегу Zacks’ Biotech Analyst

Zacks SCR Best of 2026 Radiopharm Theranostics
Zacks SCR Best of 2026 Radiopharm Theranostics
2026 Small-Cap Outlook: Zacks Analysts Share Their Top Investment Picks
2026 Small-Cap Outlook: Zacks Analysts Share Their Top Investment Picks
Lexaria CEO on DehydraTECH and Oral GLP-1s
Lexaria CEO on DehydraTECH and Oral GLP-1s
Zacks SCR's Initiation of TuHURA Biosciences (HURA)
Zacks SCR's Initiation of TuHURA Biosciences (HURA)
Top Stock Picks for Week of February 9, 2026
Top Stock Picks for Week of February 9, 2026
AI boom is driving new Zacks #1 stocks
AI boom is driving new Zacks #1 stocks
Top Stock Picks for Week of February 2, 2026
Top Stock Picks for Week of February 2, 2026
Venture Capital trends in 2018 from Zacks analyst John Vandermosten
Venture Capital trends in 2018 from Zacks analyst John Vandermosten
Zacks analyst John Vandermosten bullish on Dyadic International's C1 gene expression platform
Zacks analyst John Vandermosten bullish on Dyadic International's C1 gene expression platform
3 лучшие из лучших акций с самым высоким рейтингом
3 лучшие из лучших акций с самым высоким рейтингом
An Overview of Leading Stocks in Biotechnology
An Overview of Leading Stocks in Biotechnology
The Zacks Analyst NVIDIA, Intel, Advanced Micro Devices and Alibaba Group Holding #Shorts
The Zacks Analyst NVIDIA, Intel, Advanced Micro Devices and Alibaba Group Holding #Shorts
Zacks Small Cap Research Initiates Coverage on CVKD
Zacks Small Cap Research Initiates Coverage on CVKD
CEO Chat with Anil Diwan, President & Executive Chairman at NanoViricides, Inc.
CEO Chat with Anil Diwan, President & Executive Chairman at NanoViricides, Inc.
Choose Your Fighter: Protalix Biotherapeutics (NASDAQ: PLX) Punching Above its Weight
Choose Your Fighter: Protalix Biotherapeutics (NASDAQ: PLX) Punching Above its Weight
NurExone's Path Forward | CEO Chat with Dr. Lior Shaltiel, CEO of NurExone Biologic Inc.
NurExone's Path Forward | CEO Chat with Dr. Lior Shaltiel, CEO of NurExone Biologic Inc.
Should You Buy Beaten-Down Biotech Stocks & ETFs?
Should You Buy Beaten-Down Biotech Stocks & ETFs?
2017 Biotech Year in review with John Vandermosten from Zacks Small Cap Research
2017 Biotech Year in review with John Vandermosten from Zacks Small Cap Research
Addressing Coronavirus Fears and Screening for Biotech Stocks with John Vandermosten, Zack's SCR
Addressing Coronavirus Fears and Screening for Biotech Stocks with John Vandermosten, Zack's SCR